RT @RHEUMarampa: Promising results of Risankizumab for #psoriaticarthritis ð¸Pts significantly achieved higher rates
Tweet Content
Promising results of Risankizumab for #psoriaticarthritis
🔸Pts significantly achieved higher rates of ACR20, 50 and 70 response at wk 24 vs. placebo
🔸Well tolerated and showed no safety signals
@RheumNow #ACR21 #ACRBest abs0453 https://t.co/TDSLEgF68g
Show on Archive Page
On
Display in Search Results
On
PDQ
Off